An Introduction to Organ-on-a-Chip Technology

27 Jan 2025

To bring drugs to market, scientists rely on different types of preclinical models — from 2D in vitro models to lab animals — that try to replicate human in vivo conditions. As conventional preclinical models have a difficult time approximating human biology, they fall short in predicting how humans will respond to drugs. Discover how next-generation organ-on-a-chip technology can improve disease research and drug development programs to increase efficiency and bring more life-saving treatments to market.

Links

Tags